Paragon Care (FRA:PXS) LT-Debt-to-Total-Asset : 0.12 (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Paragon Care LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Paragon Care's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.12.

Paragon Care's long-term debt to total assets ratio declined from Dec. 2023 (0.25) to Dec. 2024 (0.12). It may suggest that Paragon Care is progressively becoming less dependent on debt to grow their business.

Paragon Care LT-Debt-to-Total-Asset Historical Data

The historical data trend for Paragon Care's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon Care LT-Debt-to-Total-Asset Chart

Paragon Care Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.32

0.30

0.24

0.22

0.12

Paragon Care Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.22	0.22	0.25	0.12	0.12

Paragon Care LT-Debt-to-Total-Asset Calculation

Paragon Care's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )	/	Total Assets (A: Jun. 2024 )
	=	83.321	/	697.606
	=	0.12

Paragon Care's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	91.713	/	749.224
	=	0.12

Paragon Care (FRA:PXS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Paragon Care LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Paragon Care's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Paragon Care Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (FRA:PXS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

PGC:Australia

Address

77-97 Ricketts Road, Mount Waverley, Melbourne, VIC, AUS, 3149

Website

https://www.paragoncare.com.au

Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.